1 |
Nicolle D, Fremond C, Pichon X, Bouchot A, Maillet I, Ryffel B, et al. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors: investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect Immun 2004;72:6994-7004
DOI
ScienceOn
|
2 |
Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. PNAS 1999;96:14459-63
DOI
ScienceOn
|
3 |
Leal IS, Florido M, Andersen P, Appelberg R. Interlukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine. Immunology 2001;103:375-81
DOI
ScienceOn
|
4 |
Singla A, Singh S, Goraya JS, Radhika S, Sharma M. The natural course of nonsuppurative Calmette-Guerin bacillus lymphadenitis. Pediatr Infect Dis J 2002;21:446-8
DOI
ScienceOn
|
5 |
Behr MA. BCG-different strains, different vaccines? Lancet Infect Dis 2002;2:86-92
DOI
PUBMED
ScienceOn
|
6 |
Quesniaux VJ, Nicolle DM, Torres D, Kremmer L, Guerardel Y, Nigou J, et al. Toll-like receptor 2-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004; 172:4425-34
DOI
|
7 |
Gilleron M, Quesniaux VF, Puzo G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette-Gurin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 2003;278:29880-9
DOI
ScienceOn
|
8 |
Krause SW, Kreutz M, Andreesen R. Differential effcts of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. Immunobiology 1996; 196:522-34
PUBMED
ScienceOn
|
9 |
Teo S, Smeulders N, Shingadia DV. BCG vaccine-associated suppurative lymphadenitis. Vaccine 2005;23:2676-9
DOI
ScienceOn
|
10 |
Baek HS, Chang JY, Moon SJ, Oh SH. Lymphadenitis following intradermal BCG vaccination. Korean J Pediatr 2006;49:46-50
DOI
|
11 |
Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002;99:3427-31
DOI
PUBMED
ScienceOn
|
12 |
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004;11:625-6
PUBMED
ScienceOn
|
13 |
Na KH, Rim SS, Kim EY, Kim KS, Kim YW. Factors affecting clinical course of BCG lymphadenitis. Korean J Pediatr Infect Dis 2001;8:181-90
|
14 |
Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999;401:811-5
DOI
ScienceOn
|
15 |
Heldwein KA, Liang MD, Andressen TK, Thomas KE, Marthy AM, Cuesta N, et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol 2003;74:277-86
DOI
ScienceOn
|
16 |
Kim MS, Jo DS, Kang MK, Kim SJ, Kim JS. The effect of local rifampicin instillation on the treatment of suppurative BCG lymphadenitis. Korean J Pediatr 2006;49:40-5
DOI
|
17 |
Flowaczny M, Glas J, Torok HP, Limbersky O, Flowaczny C. Toll-like receptor 2 and 4 mutations in peiodontal disease. Clin Exp Immunol 2004;135:330-5
DOI
ScienceOn
|
18 |
Hwang DH, Han JW, Choi KM, Shin KM, Kim DS. Expression of Toll-like receptor-2 on the peripheral monocytes in Kawasaki disease patients. Korean J Pediatr 2005;48:315-20
|
19 |
Link A, Selejan S, Maack C, Lenz M, Böhm M. Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock. Critical Care 2008; 12:R159
DOI
|
20 |
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-401
DOI
ScienceOn
|
21 |
Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main chracteristics. Adv Tuberc Res 1984;21:107-93
PUBMED
|
22 |
Iwahashi M, Tamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004;50:1457-67
DOI
ScienceOn
|
23 |
Han YP, Li J, Wan YF, Kong LH, Cai J, Dong L, et al. The influence of hepatitis B e antigen on the expression of toll- like receptor 2 on peripheral monocytes [abstract]. Zhonghua Gan Zang Bing Za Zhi 2008;16:739A
|
24 |
Kang TJ, Chae GT. Detection of Toll-like receptor2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001;31:53-8
DOI
ScienceOn
|
25 |
Stenger S, Modlin RL. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 2002;14:452-7
DOI
ScienceOn
|
26 |
Gilleron M, Nigou J, Nicolle D, Quesniaux V, Puzo G. The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem Biol 2006;13:39-47
DOI
ScienceOn
|
27 |
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000;164:3476-9
DOI
|
28 |
Wikén M, Grunewald J, Eklund A, Wahlström J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro- inflammatory synergy of TLR2 with NOD2 stimualtion in Sarcoidosis. J Clin Immunol 2009;29:78-89
DOI
ScienceOn
|
29 |
Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005;6:68
DOI
ScienceOn
|
30 |
Schrder NWJ, Hermann C, Hamann L, Gobel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003;81:368-72
DOI
ScienceOn
|
31 |
Yoon HJ, Choi JY, Kim CO, Park YS, Kim MS, Kim YK, et al. Lack of Toll-like receptor 4 and 2 polymorphism in Korean patients with bacteremia. J Korean Med Sci 2006;21: 979-82
DOI
ScienceOn
|